Prometic Life Sciences Inc. operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Prometic Life Sciences Inc. with three other
companies in this sector in Canada:
Epicore Bionetworks Incorporated
sales of 12.49 million Canadian Dollars [US$9.53 million]
Golden Leaf Holdings Ltd
(10.12 million Canadian Dollars [US$7.73 million]
CanniMed Therapeutics Inc
(9.80 million Canadian Dollars [US$7.48 million]
Prometic Life Sciences Inc. reported sales of C$16.39 million (US$12.51 million)
December of 2016.
decrease of 33.2%
versus 2015, when the company's sales were C$24.53 million.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Prometic Life Sciences Inc. had sales
of C$17.59 million.